Stock Price
167.05
Daily Change
1.74 1.05%
Monthly
11.79%
Yearly
15.20%
Q4 Forecast
163.43

EPS Reference Time Actual Consensus Previous
2026-11-03 FY2026Q3 PM 2.44 2.10
2026-07-28 FY2026Q2 PM 2.46 2.17 1.89
2026-05-05 FY2026Q1 PM 1.73 1.66 1.68
2026-02-24 FY2025Q4 PM 2.17 1.95 1.90
2025-10-28 FY2025Q3 PM 2.10 1.89 1.68



Peers Price Chg Day Year Date
Acacia Research 4.32 -0.07 -1.59% 28.57% Oct/09
CBIZ 54.82 0.02 0.04% 2.68% Oct/09
Capita 235.00 19.50 9.05% -32.95% Oct/09
CRA International 176.73 -0.83 -0.47% -0.12% Oct/09
CoStar 29.67 -0.14 -0.47% -60.74% Oct/09
ExlService 36.79 -0.08 -0.22% -10.81% Oct/09
Exponent 69.81 0.03 0.04% 6.96% Oct/09
Franklin Covey 341.95 7.08 2.11% -9.03% Oct/09
FTI Consulting 136.16 -4.34 -3.09% -15.79% Oct/09
Fiserv 45.63 -0.31 -0.67% -62.79% Oct/09

Indexes Price Day Year Date
USND 27366 172.83 0.64% 23.25% Oct/09
US2000 2807 12.85 0.46% 17.22% Oct/09

Huron Consulting traded at $167.05 this Friday October 9th, increasing $1.74 or 1.05 percent since the previous trading session. Looking back, over the last four weeks, Huron Consulting gained 11.79 percent. Over the last 12 months, its price rose by 15.20 percent. Looking ahead, we forecast Huron Consulting to be priced at 163.43 by the end of this quarter and at 153.02 in one year, according to Trading Economics global macro models projections and analysts expectations.

Huron Consulting Group Inc. is a global professional services firm. The Company offers solutions in operations, advisory services, technology and analytics. The Company's segments include Healthcare, Education and Life Sciences, and Business Advisory. Its Healthcare segment provides advisory services, from strategy setting through implementation, in the areas of organizational and resource alignment, clinical transformation, financial and operational performance, patient and caregiver engagement, and technology implementation and optimization. Its Education and Life Sciences segment provides management consulting and technology solutions to the higher education and academic medical centers, pharmaceutical and medical device, biotechnology and research industries. The Business Advisory segment's primary service lines include Enterprise Solutions and Analytics, and Business Advisory. The Business also enables clients to manage the data to optimize the operations and drive cloud adoption.